help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rabbani, S. A.
Right arrow Articles by Goltzman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rabbani, S. A.
Right arrow Articles by Goltzman, D.

Endocrinology, Vol 123, 2709-2716, Copyright © 1988 by Endocrine Society


ARTICLES

Influence of the amino-terminus on in vitro and in vivo biological activity of synthetic parathyroid hormone-like peptides of malignancy

SA Rabbani, J Mitchell, DR Roy, GN Hendy and D Goltzman
Department of Physiology, McGill University, Montreal, Quebec, Canada.

We compared the bioactivities of a synthetic truncated NH2-terminal fragment of the human (h) PTH-like peptide (PLP) associated with malignancies [hPLP-(3-34)], an intact NH2-terminal fragment [hPLP-(1- 34)], and an NH2-terminal fragment of PTH [hPTH-(1-34)]. Although hPLP- (1-34) was less potent than hPTH-(1-34) in stimulating adenylate cyclase in rat renal membranes, hPLP-(1-34) and hPTH-(1-34) were equipotent in stimulating adenylate cyclase in OK renal cells as well as in UMR 108 osteosarcoma cells in vitro. In osteosarcoma cells, each of these peptides could desensitize adenylate cyclase responses to itself and to the other peptide, but could not reduce stimulation by prostaglandin E2. Renal membranes of vitamin D-deficient rats with secondary hyperparathyroidism had a reduced PLP-stimulated as well as PTH-stimulated adenylate cyclase response. The truncated analog hPLP-(3- 34) was only a weak partial agonist and an antagonist in vitro, produced equivalent inhibition of hPLP-(1-34) and hPTH-(1-34) in renal and osseous cells, and could not desensitize agonist responses. In thyroparathyroidectomized rats in vivo, hPLP-(1-34) and hPTH-(1-34) increased cAMP excretion, enhanced phosphaturia, maintained plasma calcium, and reduced calciuria. Equimolar concentrations of hPLP-(3-34) produced no increases above control levels; however, high concentrations of this peptide mimicked PTH actions on renal and plasma ion handling while modestly augmenting cAMP excretion. These results demonstrate the importance of the first two residues of PLP for bioactivity, indicate that PLP and PTH interact at common receptor sites in vivo as well as in vitro, suggest that PLP may not be less potent than PTH in renal target cells, and indicate that the net result of interaction of these peptides with their common receptor in target tissues may reflect both activation and desensitization of receptor- mediated events.


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
T. Massfelder, N. Taesch, S. Fritsch, A. Eichinger, M. Barthelmebs, A. F. Stewart, and J.-J. Helwig
Type 1 Parathyroid Hormone Receptor Expression Level Modulates Renal Tone and Plasma Renin Activity in Spontaneously Hypertensive Rat
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 639 - 648.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Fraher, R. Avram, P. H. Watson, G. N. Hendy, J. E. Henderson, K. L. Chong, D. Goltzman, P. Morley, G. E. Willick, J. F. Whitfield, et al.
Comparison of the Biochemical Responses to Human Parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in Healthy Humans
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2739 - 2743.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Jono, Y. Nishizawa, A. Shioi, and H. Morii
Parathyroid Hormone–Related Peptide as a Local Regulator of Vascular Calcification: Its Inhibitory Action on In Vitro Calcification by Bovine Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1135 - 1142.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Yamamoto, I. Morimoto, N. Yanagihara, K. Zeki, T. Fujihira, F. Izumi, H. Yamashita, and S. Eto
Parathyroid Hormone-Related Peptide-(1-34) [PTHrP- (1-34)] Induces Vasopressin Release from the Rat Supraoptic Nucleus in Vitro through a Novel Receptor Distinct from a Type I or Type II PTH/PTHrP Receptor
Endocrinology, May 1, 1997; 138(5): 2066 - 2072.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Azarani, D. Goltzman, and J. Orlowski
Structurally Diverse N-terminal Peptides of Parathyroid Hormone (PTH) and PTH-related Peptide (PTHRP) Inhibit the Na+/H+ Exchanger NHE3 Isoform by Binding to the PTH/PTHRP Receptor Type I and Activating Distinct Signaling Pathways
J. Biol. Chem., June 21, 1996; 271(25): 14931 - 14936.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Azarani, J. Orlowski, and D. Goltzman
Parathyroid Hormone and Parathyroid Hormone-related Peptide Activate the Na[IMAGE]/H[IMAGE] Exchanger NHE-1 Isoform in Osteoblastic Cells (UMR-106) via a cAMP-dependent Pathway
J. Biol. Chem., September 29, 1995; 270(39): 23166 - 23172.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Azarani, D. Goltzman, and J. Orlowski
Parathyroid Hormone and Parathyroid Hormone-related Peptide Inhibit the Apical Na[IMAGE]/H[IMAGE] Exchanger NHE-3 Isoform in Renal Cells (OK) via a Dual Signaling Cascade Involving Protein Kinase A and C
J. Biol. Chem., August 25, 1995; 270(34): 20004 - 20010.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society